Benzinga
Benzinga
Benzinga
lunes, septiembre 28

Johnson & Johnson

JNJNYSE
Trade with Public
Trade with Public
$271.95
0.730.27%
al cierre: Sep 28, 5:00 PM EST
$272.12
0.170.06%
After hour: 5:19 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Johnson & Johnson Financials

Johnson & Johnson (JNJ) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Stock Market Today: Dow Jones Futures Gain as Coca-Cola Jumps After Q2 Beat, S&P 500, Nasdaq 100 Decline—Boeing, Johnson & Johnson in Focus (UPDATED)

U.S. stock futures were mixed on Tuesday, as the Dow Jones and S&P 500 indices gained but Nasdaq 100 slipped, following Monday's mixed close.
Rishabh Mishra

Johnson & Johnson Posts Upbeat Q2: IM Momentum Building Into 2027, Says Bullish Analyst

The reasons why RBC Capital Markets maintains its stock rating.
Priya Nigam

Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook

Johnson & Johnson beats Q2 2026 Wall Street estimates and raises full-year guidance as sales top $25B, driven by oncology and MedTech.
Vandana Singh

Earnings Scheduled For July 15, 2026

Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per
Benzinga Insights

PRO
Johnson & Johnson Raises FY2026 Adj EPS Guidance from $11.45-$11.65 to $11.60-$11.75 vs $11.59 Est; Raises FY2026 Sales Guidance from $100.300B-$101.300B to $100.800B-$101.400B vs $101.022B Est

Johnson & Johnson (NYSE:JNJ) raises FY2026 Adj EPS guidance from $11.45-$11.65 to $11.60-$11.75 vs $11.59 analyst estimate. Raises FY2026 sales outlook from $100.300 billion-$101.300 billion to $100.800
Benzinga Newsdesk

PRO
Johnson & Johnson Q2 Adj. EPS $2.90 Beats $2.85 Estimate, Sales $25.310B Beat $25.047B Estimate

]
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved